ECCI (ECCI) Stock Price & Analysis
ECCI (ECCI) rose 0.00% to USD 0 as of June 10, 2026 at 07:53 UTC, according to Nexqual real-time market data.
ECCI last closed at USD 0; the session ranged USD 0–0 on volume of 6,500 shares. Market capitalization is $52,281, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 07:53 UTC.
Key Statistics (as of June 10, 2026 at 07:53 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 6,500 shares |
| Market Cap | $52,281 |
| Exchange | PNK |
Technical Analysis (ECCI)
Nexqual's technical model rates ECCI "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 07:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (ECCI)
Wall Street analysts rate ECCI "None", per Nexqual as of June 10, 2026 at 07:53 UTC.
| Consensus Rating | None |
|---|
Earnings (ECCI)
Source: Nexqual, June 10, 2026 at 07:53 UTC.
Financials & Fundamentals (ECCI)
| Total Revenue | $517,365 |
|---|---|
| Revenue Growth (YoY) | +721.30% |
| Gross Margin | -14.39% |
| Operating Margin | -634.70% |
| Profit Margin | +0.00% |
| Current Ratio | 0.2 |
| Total Cash | $9,328 |
| Total Debt | $1.86M |
| Free Cash Flow | $-382,691 |
Source: Nexqual, June 10, 2026 at 07:53 UTC.
Financial Health Score (ECCI)
Nexqual rates ECCI's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:53 UTC.
| Growth | Strong — Revenue +721% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $9K cash vs $2M debt |
| Cash Flow | Weak — FCF negative: -$383K, burning cash |
| Efficiency | Mixed — No data |
Ownership (ECCI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.05% |
| Shares Outstanding | 0 |
Source: Nexqual, June 10, 2026 at 07:53 UTC.
Leadership (ECCI)
ECCI is led by Royis Ward (age 91), Chairman, Chief Executive Officer, President and Chief Financial Officer, per Nexqual as of June 10, 2026 at 07:53 UTC.
| Chairman, Chief Executive Officer, President and Chief Financial Officer | Royis Ward (age 91) |
|---|---|
| Chief Operating Officer and Vice President | John Adams |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHMB | PHARMACOM BIOVET INC | USD 0 | ▲ 0% |
| DLAD | DEALERADVANCE INC | USD 0 | ▲ 0% |
| RMTD | REMOTE DYNAMICS INC | USD 0 | ▲ 0% |
| SMAS | SOMATIC SYSTEMS INC | USD 0 | ▲ 0% |
| EWKS | EARTHWORKS ENTERTAINMENT INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:53 UTC. This page is informational and not investment advice.